Target
RAC-alpha serine/threonine-protein kinase
Ligand
BDBM50380939
Substrate
n/a
Meas. Tech.
ChEMBL_814031 (CHEMBL2020583)
IC50
1±n/a nM
Citation
 Rice, KDKim, MHBussenius, JAnand, NKBlazey, CMBowles, OJCanne-Bannen, LChan, DSChen, BCo, EWCostanzo, SDeFina, SCDubenko, LEngst, SFranzini, MHuang, PJammalamadaka, VKhoury, RGKlein, RRLaird, ADLe, DTMac, MBMatthews, DJMarkby, DMiller, NNuss, JMParks, JJTsang, THTsuhako, ALWang, YXu, W Pyrazolopyrimidines as dual Akt/p70S6K inhibitors. Bioorg Med Chem Lett 22:2693-7 (2012) [PubMed]  Article 
Target
Name:
RAC-alpha serine/threonine-protein kinase
Synonyms:
AKT phosphorylation (p-AKT) | AKT1 | AKT1/PPP1CA | AKT1_HUMAN | C-AKT | PKB | PKB alpha | Protein kinase Akt-1 | Protein kinase B | Protein kinase B (AKT1) | Protein kinase B (Akt 1) | Protein kinase B (Akt) | Protein kinase B alpha | Protein kinase B alpha (AKT1) | Proto-oncogene Akt (Akt1) | Proto-oncogene c-Akt (AKT) | Proto-oncogene c-Akt (AKT1) | RAC | RAC-PK-alpha | RAC-alpha serine/threonine-protein kinase (AKT) | RAC-alpha serine/threonine-protein kinase (AKT1) | RAC-alpha serine/threonine-protein kinase (pAKT)
Type:
Enzyme
Mol. Mass.:
55681.25
Organism:
Homo sapiens (Human)
Description:
P31749
Residue:
480
Sequence:
MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA
  
Inhibitor
Name:
BDBM50380939
Synonyms:
CHEMBL2016893
Type:
Small organic molecule
Emp. Form.:
C26H32BrF3N8O
Mol. Mass.:
609.484
SMILES:
Cc1c(NCCN2CCCC2)cc(cc1N1CCN(CC1)c1ncnc2n[nH]c(Br)c12)C(=O)CCC(F)(F)F
Structure:
Search PDB for entries with ligand similarity: